Also, thesubstantially different concentrations of PPARγ antagonists needed to induce anti-invasiveeffects versus growth inhibition in esophageal cancer lines suggest differentmechanisms with differing degrees of PPARγ dependence or lack of involvement of the PPARγ-signaling pathway for some effects. This evidence concerns the gene PPARG and esophageal cancer.